Injecting DNA into injured horse tendons and ligaments can cure lameness, new research involving scientists at Kazan Federal University, Moscow State Academy and The University of Nottingham has found.
The gene therapy technology was used in horses that had gone lame due to injury and within two to three weeks the horses were able to walk and trot. Within just two months they were back to full health, galloping and competing.
The study has big implications not just for the veterinary world but the future of human medicine – injuries like these are common in people as well as animals, not just in lameness but in other illnesses and diseases from the legs and arms through to the back and hips.
The new findings are the result of a partnership between the Kazan Federal University and Moscow State Academy of Veterinary Medicine and Biotechnology and Nottingham’s School of Veterinary Medicine and Science.
Dr Catrin Rutland, Assistant Professor of Anatomy and Developmental Genetics, led the work at Nottingham.
She said: “This pioneering study advances not only equine medicine but has real implications for how other species and humans are treated for lameness and other disorders in the future. The horses returned to full health after their injuries and did not have any adverse side effects. This is a very exciting medical innovation.”
The ground-breaking, international study, published in the academic journal Frontiers in Veterinary Science, demonstrated gene therapy using a combination of the Vascular Endothelial Growth Factor gene VEGF164, to enhance the growth of blood vessels and bone morphogenetic protein 2 (BMP2), which plays an important role in the development of bone and cartilage.
Both the genes were derived from horses, resulting in the biosynthesis of natural horse proteins in the treated animals. They were cloned into a single plasmid DNA, which is both biologically safe and unlikely to provoke an immune reaction from the body.
Current medical therapies have a relapse rate of 60 per cent and even the best regenerative medicine treatments have a 20 per cent relapse rate and take five to six months to work.
The new therapy is therefore very promising as it offers a much faster healing time and could significantly reduce relapse rates.
The results also showed that the tissue within the horses limbs has also fully recovered and 12 months after the revolutionary treatment the horses were completely fit, active and pain free.
Many medicines and treatments have adverse effects, but no side effects or bad reactions were seen in the horses treated.
Professor Albert Rizvanov, who led the study and is based at Kazan Federal University, said: “Advancing medicine, relieving pain and restoring function were the main aims of this study. We have shown that these are possible and within a much shorter time span than treatments available at the moment. In addition, we could use this type of therapy in other injuries and in many other situations ranging from fertility problems through to spinal cord injuries.
“Our next step is to secure more funding for an even larger trial to help more animals and improve and treat other disorders in the hope that one day we can routinely use this treatment around the world.”
The Latest on: Gene therapy
- Akouos to Present Data from Inner Ear Gene Therapy Platform at 23rd ASGCT Annual Meetingon May 11, 2020 at 12:50 pm
Akouos, a precision genetic medicine company developing gene therapies to potentially restore, improve and preserve hearing, announced today that data from its inner ear gene therapy platform will be ...
- Orchard Therapeutics: A Leading Gene Therapy Company For Your Watchliston May 11, 2020 at 12:16 pm
By acquiring GSK's gene therapy assets, ORTX has propelled itself into a leading position here. It has a number of programs it is rapidly advancing through tria ...
- Nanopropellers to Deliver Gene Therapy Into Cellson May 11, 2020 at 9:04 am
Researchers at the Max Planck Institute for Intelligent Systems in Germany have developed powerful nanopropellers that can be steered into the interior of ...
- Gene therapy cuts fat and builds muscle in sedentary mice on unhealthy dietson May 11, 2020 at 5:55 am
A single injection of the gene that makes the protein follistatin caused a significant buildup of muscle mass in mice while also preventing obesity, reported Washington University researchers. The ...
- Exec team behind $165M gene therapy acquisition back with another Nationwide Children's spinouton May 11, 2020 at 5:06 am
The executive team that led a gene therapy spinout to a $165M acquisition is back with another @NationwideKids spinout, this time attacking antibiotic-resistant bacteria with a new biotech approach.
- Novartis, Sarepta partner with new George Church gene therapy startupon May 11, 2020 at 5:00 am
Dyno Therapeutics launched Monday with plans to use artificial intelligence to expand the use of gene therapy. The company was co-founded by George Church, the noted Harvard University geneticist, and ...
- Dyno Therapeutics Emerges from Stealth to Transform Gene Therapy Using Artificial Intelligenceon May 11, 2020 at 4:16 am
Dyno Therapeutics, Inc., a biotechnology company applying artificial intelligence (AI) to gene therapy, today announced the company’s launch from stealth mode with its proprietary platform, CapsidMap™ ...
- Dyno Debuts With Plan, Partnerships For Better Gene Therapy Vectorson May 11, 2020 at 4:04 am
The Cambridge, MA-based biotech emerged from stealth Monday having signed deals with two drug makers who want to apply its technology to their gene therapy efforts—agreements its founders say are ...
- Novartis, Sarepta tap Dyno to unearth new gene therapy vectorson May 11, 2020 at 4:00 am
Although gene therapy has opened a new realm of possibilities, its delivery vehicles have held it back. Dyno Therapeutics is on a mission to change that—and it’s coming out of stealth with ...
- Experimental gene therapy prevents obesity, builds muscle, without exercise or dietingon May 10, 2020 at 6:34 pm
A compelling new study, led by scientists from Washington University School of Medicine in St. Louis, has found a novel gene therapy can prevent obesity and build muscle without the need for ...
via Google News and Bing News